McCulloch Kevin
SEC insider (Form 3/4/5 filer). CIK 0002031695. Officer at Xeris Biopharma Holdings, Inc. (XERS). 22 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in CHICAGO, IL.
Companies McCulloch Kevin has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Officer, See Remarks
McCulloch Kevin
CIK: 0002031695
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Oct 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15K shares at avg. $9.41$141K - Sep 28, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect25K shares at avg. $10.00$250K - Sep 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15K shares at avg. $8.49$127K - Aug 3, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15K shares at avg. $8.02$120K - Aug 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect21.9K shares at avg. $8.08$177K - Jul 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect90K shares at avg. $8.03$723K - Mar 12, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect4 shares at avg. $3.94$15.76 - Mar 12, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect48.9K shares at avg. $4.09$200K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect27.3K shares at avg. $7.36$201K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect68.5K shares at avg. $7.36$504K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 15,000 | $9.41 | $141,120 | Direct |
| Sep 28, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 25,000 | $10.00 | $250,000 | Direct |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 15,000 | $8.49 | $127,308 | Direct |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 15,000 | $8.02 | $120,240 | Direct |
| Aug 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 21,918 | $8.08 | $177,097 | Direct |
| Jul 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 90,000 | $8.03 | $722,511 | Direct |
| Mar 12, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 4 | $3.94 | $16 | Direct |
| Mar 12, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 48,894 | $4.09 | $199,976 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 27,319 | $7.36 | $201,068 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 68,454 | $7.36 | $503,821 | Direct |
1-10 of 22 transactions